Search Results - "Hinterlang M"

Exploring prospective polymers for clarithromycin mucoadhesivegastroretentive granules.

Authors: Putri, Kurnia Sari Setio Akbar, Rayhan Satria, Dave Jason et al.

Source: Journal of Applied Pharmaceutical Science. Apr2026, Vol. 16 Issue 4, p221-232. 12p.

Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease.

Authors: Hinterlang M Sebti M Cotteret C et al.

Source: TheScientificWorldJournal [ScientificWorldJournal] 2022 Jun 02; Vol. 2022, pp. 1931118. Date of Electronic Publication: 2022 Jun 02 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101131163 Publication Model: eCollection Cited Medium: Internet ISSN: 1537-744X (Electronic) Linking ISSN: 1537744X NLM ISO Abbreviation: ScientificWorldJournal Subsets: MEDLINE

Special Issue "Recent Advances in Oral Drug Delivery Development".

Authors: Schlatter, Joël¹ (AUTHOR) joel.schlatter@aphp.fr

Source: Pharmaceuticals (14248247). Sep2023, Vol. 16 Issue 9, p1289. 3p.

Real-world use of non-oral administration of oral anticancer agents via the simple suspension method in Japanese patients with cancer: A nationwide claims-based analysis.

Authors: Ohta, Hiroaki Yasu, Takeo

Source: Drug Discoveries & Therapeutics. Dec2025, Vol. 19 Issue 6, p378-388. 11p.

A Phase 1, Open‐Label, Randomized, Two‐Part Study in Healthy Adult Volunteers to Evaluate the Bioavailability of the Maribavir Powder for Oral Suspension, as Well as Food Effect and Impact of Rabeprazole.

Authors: Campagne, Olivia Ilic, Katarina Gabriel, Andre et al.

Source: Clinical Pharmacology in Drug Development. Feb2025, Vol. 14 Issue 2, p133-143. 11p.

Dispensing Oral Temozolomide in Children: Precision and Stability of a Novel and Ready to Use Liquid Formulation in Comparison with Capsule Derived Mixtures.

Authors: Lemarchand, Caroline Bienaymé, Hugues Rieutord, André et al.

Source: Pharmaceutics. Dec2023, Vol. 15 Issue 12, p2711. 14p.

A Multicenter Randomized Bioequivalence Study of a Novel Ready-to-Use Temozolomide Oral Suspension vs. Temozolomide Capsules.

Authors: Ducray, François Ramirez, Carole Robert, Marie et al.

Source: Pharmaceutics. Dec2023, Vol. 15 Issue 12, p2664. 20p.

Status analysis of quality control of administered infusion solution with cytotoxic drugs.

Authors: Wang, Shan Zhang, Feng-Ying Dou, Xue et al.

Source: Oncology Reviews. 2025, p1-12. 12p.

Development of a Hospital Compounded, Taste-Masked, Temozolomide Oral Suspension and 5-Year Real-Life Experience in Treating Paediatric Patients.

Authors: Annereau, Maxime Hinterlang, Mélanie Bienayme, Hugues et al.

Source: Pharmaceuticals (14248247). May2022, Vol. 15 Issue 5, p555-555. 15p.

Development of an Oral Liquid Formulation of Nicardipine Hydrochloride Compounded with Simple Excipients for the Treatment of Pediatric Hypertension.

Authors: Cavelier, Marine Gondé, Henri Costa, Damien et al.

Source: Pharmaceutics. Feb2023, Vol. 15 Issue 2, p446. 19p.

Compounding and stability studies of liquid oral formulations of beta-blockers (bisoprolol, betaxolol, and nadolol) for paediatric patients.

Authors: Dubois L Bouguergour C Paoli-Lombardo R et al.

Source: Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques [J Pharm Pharm Sci] 2025 Dec 02; Vol. 28, pp. 15387. Date of Electronic Publication: 2025 Dec 02 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Media S. A Country of Publication: Switzerland NLM ID: 9807281 Publication Model: eCollection Cited Medium: Internet ISSN: 1482-1826 (Electronic) Linking ISSN: 14821826 NLM ISO Abbreviation: J Pharm Pharm Sci Subsets: MEDLINE

Design and stability of pediatric oral formulation of imatinib.

Authors: Hinterlang M Gendron A Fleury T et al.

Source: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2022 Mar; Vol. 28 (2), pp. 337-342. Date of Electronic Publication: 2021 Jan 31.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

Editorial: Non-tuberculous mycobacteria infections and COVID-19.

Authors: Venketaraman V; Department of Basic Medical Sciences, Western University of Health Sciences, Pomona, CA, United States.

Source: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2025 Feb 12; Vol. 15, pp. 1550277. Date of Electronic Publication: 2025 Feb 12 (Print Publication: 2025).

Publication Type: Editorial

Journal Info: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE; In Process

Homelessness, Poverty, and Unemployment

Authors: Thompson, Sanna J.

Resource Type: eBook.

Subjects: Unemployment--United States, Homelessness--United States, Poor--United States

Categories: SOCIAL SCIENCE / Poverty & Homelessness